insights_auto
Why is SCNI up 5.33%?
Dive Deeperchevron_right
SCNI:NASDAQ
Scinai Immunotherapeutics Ltd - ADR
$1.78
arrow_upward
+5.33%(+0.090) 1D
Sep 22, 2:26:25 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for SCNI...
Open
$1.61
High
$1.79
Low
$1.57
Mkt. cap
1.01M
Avg. vol.
2.35M
Volume
338.05K
52-wk high
$16.30
52-wk low
$1.43
EPS
-$2.80
Beta
2.08
Shares outstanding
706.59K
No. of employees
45
Open
$1.61
High
$1.79
Low
$1.57
Mkt. cap
1.01M
Avg. vol.
2.35M
Volume
338.05K
52-wk high
$16.30
52-wk low
$1.43
EPS
-$2.80
Beta
2.08
Shares outstanding
706.59K
No. of employees
45
News stories
From web sources and news partners
Benzinga
·
1 day ago
12 Health Care Stocks Moving In Monday's Pre-Market Session
Timothy Sykes
·
1 day ago
SCNI Stock Wobbles As Scinai Refocuses On NanoAb Platform
TipRanks
·
1 day ago
Scinai Immunotherapeutics Restores Nasdaq Minimum Bid Price Compliance
Investing.com
·
1 day ago
Scinai regains compliance with Nasdaq minimum bid price rule
Profile
BiondVax Pharmaceuticals Ltd. is an Israeli biopharmaceutical company focused on developing and manufacturing immunotherapeutic products, primarily for the treatment of infectious diseases and autoimmune diseases.
In collaboration with the Max Planck Institute for Multidisciplinary Sciences and the University Medical Center Göttingen, both in Germany, BiondVax develops nanosized antibody therapies for diseases such as COVID-19, asthma and psoriasis. Wikipedia
About Scinai Immunotherapeutics Ltd - ADR